[Neurology: what's new in 2023]

Area of Science:

• Neurology
• Neuroscience
• Pharmacology

Context:

• The year 2023 introduced significant advancements in neurological disorder management and diagnostics.
• Emerging research addressed critical aspects of Alzheimer's disease, multiple sclerosis, and migraine.
• New therapeutic agents and diagnostic tools reshaped the clinical landscape.

Purpose:

• To provide a concise overview of key 2023 breakthroughs in neurology.
• To highlight advancements in Alzheimer's disease treatment, biomarker utility, and neurodegenerative disease research.
• To summarize progress in managing migraines, cerebrovascular diseases, and multiple sclerosis.

Summary:

• Lecanemab's market entry marks a new era for Alzheimer's disease treatment.
• Novel biomarkers aid in monitoring peripheral neuropathies and diagnosing synucleinopathies.
• Genetic insights into nervous system cells inform multiple sclerosis (MS) progression risk.
• Anticonvulsant treatment effects on lipid metabolism and prenatal exposure are clarified.
• Anti-CGRP treatments show efficacy for migraine management.
• Thrombectomy criteria have been expanded.
• Rehabilitation strategies are improving care for cerebrovascular patients and secondary progressive MS.

Impact:

• These advancements offer improved diagnostic accuracy and therapeutic options for patients with neurological conditions.
• The findings underscore the importance of personalized medicine and targeted therapies in neurology.
• Continued research and clinical application of these innovations promise better patient outcomes.